Tylenol Shortages Continue
It may be a new year, but it’s the same old headaches for the maker of Tylenol. Johnson and Johnson says production problems continue to…
Pain Medication
FDA Approves New Migraine Patch
Millions of Americans who suffer from migraine will soon have a new treatment option – one that doesn’t come in a bottle or pill. It’s…
Why Morphine Doesn’t Always Work
Morphine has long been considered the “gold standard” when it comes to pain relief. A potent and addictive painkiller derived from opium, morphine has been…
Generic Opana Painkiller Coming to U.S.
A generic version of the painkiller Opana is set to hit the U.S. market at the start of the New Year after drug maker Endo…
Aspirin Use May Damage Eyes of Seniors
The long-term use of aspirin by seniors may increase the risk of developing late age-related macular degeneration (AMD), according to a new study published in…
Analyst: Zohydro Could Still Win FDA Approval
Zohydro, a new opioid painkiller developed by San Diego-based Zogenix (NASDAQ: ZGNX), could still be approved by the Food and Drug Administration to treat chronic…
FDA Panel Rejects New Painkiller Zohydro
A government panel of pain experts has advised the Food and Drug Administration to reject Zohydro, a new and stronger version of hydrocodone, because of…
Endo Recalls More “Super Potent” Vicodin Tablets
Endo Health Solutions (NASDAQ: ENDP) has greatly expanded a voluntary recall of its generic version of Vicodin because the painkilling tablets may be “super potent”…